Private equity firm Carlyle Group on Friday announced that it has agreed to acquire up to a 74 per cent stake in Indian animal healthcare company SeQuent Scientific Limited for about $210 million (Rs 1,580 crore).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
